Sri Lanka to receive safer medications with new DHL Life Sciences facility

DHL Global Forwarding, a leading international provider of air, sea and road freight services HQed in Germany, has launched the first-of-its-kind Life Sciences facility in Colombo designed to ensure world-class product safety and availability for Sri Lanka’s drug manufacturers and importers.
With automated temperature monitors covering its entire campus including a cool-room chilled to 2-8°C, the new facility offers Sri Lankan pharmaceutical companies a highly controlled environment for medication storage and distribution, one that complies fully with global Good Distribution Practice standards for medicinal products.
“The new Life Sciences facility gives Sri Lankan pharma companies a chance to tackle product risk at every point of the storage and distribution process, while also dramatically improving the efficiency of how they prepare their products to go to market,” said Thomas Tieber, CEO, DHL Global Forwarding ASEAN and South Asia. “That means both local and overseas drug manufacturers can deliver higher product volumes in less time and with greater assurance of quality — a powerful value proposition for those seeking to establish themselves as suppliers of choice in Sri Lanka’s increasingly privatized healthcare market[1].”
“With this latest facility in Sri Lanka, we hope to provide the life sciences and healthcare sector with the top-tier infrastructure that they need to service the burgeoning domestic demand for pharmaceutical goods, and also establish them as leaders in drug safety and availability on the world stage.”
Alongside storage and domestic distribution, the Life Sciences facility also offers a range of value-added services including labelling, price-marking and bundling of pharmaceutical finished goods.
“Sri Lanka’s medical and pharmaceutical imports have skyrocketed in recent years to hit US$460m in 2015[2], yet hospitals and clinics still face persistent quality-control issues associated with unregulated temperature, inconsistent inventory, and delayed distribution of medications[3] – all of which put patients’ lives at risk,” said Najeeb-ur Rahman, Country Manager, DHL Global Forwarding Sri Lanka. “As Sri Lanka’s healthcare sector faces the twofold pressures of an ageing population and rising incidence of chronic diseases[4], both drug manufacturers and hospitals will need safe, reliable and efficient supply chain infrastructure to keep up with citizens’ needs.”
“The new Colombo Life Sciences facility aims to streamline the entire process so that all parties — from producer to patient – can have the utmost trust in the integrity of their medications, backed up by full adherence to the Good Distribution Practice standards that underpin the world’s best medical supply chains.”
DHL is a leading global brand in the logistics industry. With about 350,000 employees in more than 220 countries and territories worldwide, DHL connects people and businesses securely and reliably, enabling global trade flows.

[1] http://www.sundaytimes.lk/150208/business-times/preserving-free-health-under-sri-lankas-privatisation-policy-134353.html
[2] http://www.treasury.gov.lk/documents/10181/12870/2015/68f51df3-5465-4805-ab6f-4a024ec672f6?version=1.1 Page 66
[3] http://www.searo.who.int/entity/medicines/sri_lanka_mar_2016.pdf?ua=1 Page 29
[4] http://www.lankabusinessonline.com/private-health-care-driven-by-aging-population-and-rising-income-fitch/